Method for the manufacturing of an oral vaccine against rabies in wild carnivores

KZ38374BUndetermined Publication Date: 2026-11-06LLP RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY PROBLEMS
0 Cites 0 Cited by

Patent Information

Application Number
KZ20250260
Authority / Receiving Office
KZ · KZ
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-03-18
Publication Date
2026-11-06
Estimated Expiration
2045-03-18
Patent Text Reader

Abstract

The invention relates to veterinary science and biotechnology, specifically to the preparation of an anti-rabies vaccine for the oral immunization of wild carnivores against rabies. The anti-rabies vaccine comprises a vaccine strain obtained from a fixed rabies virus, reproduced in a continuous BSR Syrian hamster kidney cell line, and nutritional and excipient components. The primary agent used is viral biomass containing the avirulent Rabies virus strain Rabies virus fix / NIIPBB / 2024. Fishmeal and microcrystalline cellulose, which also contain the marker tetracycline, are used as food and molding components. The method for producing an oral vaccine against rabies in wild carnivores includes the reproduction of the avirulent strain Rabies virus fix / NIIPBB / 2024 in a continuous BSR cell line by a suspension method using microcarriers or a pseudosuspension method on macrocarriers, carrying out multiple collections of virus-containing culture fluid every 48 hours with replacement of the maintenance medium, bottling of virus-containing culture fluid with an infectious activity of at least 6.00 MLD₅₀ / cm³ in 3 g portions into polyethylene containers, followed by freezing at a temperature of minus 20°C, preparation of a bait composition from fish meal, microcrystalline cellulose and tetracycline, placing the frozen polyethylene container inside the molded bait, covering the surface of the mold with paraffin and storing the finished vaccine at a temperature of minus 20°C. The technical result consists in increasing the efficiency due to an increase in the antigenic and immunogenic activity of the vaccine.
Need to check novelty before this filing date? Find Prior Art